Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Microbot Medical ( (MBOT) ) has provided an announcement.
On September 17, 2025, Microbot Medical Inc. awarded special one-time cash bonuses to its executive officers, acknowledging their salary waivers as part of a cost restructuring plan earlier in May 2023. The company also amended the compensation package for its non-management board members, granting them one-time cash payments, reflecting strategic financial adjustments to support its leadership and governance.
The most recent analyst rating on (MBOT) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
More about Microbot Medical
Microbot Medical Inc. operates in the medical technology industry, focusing on the development of innovative robotic medical devices.
Average Trading Volume: 3,579,732
Technical Sentiment Signal: Buy
Current Market Cap: $151.2M
Find detailed analytics on MBOT stock on TipRanks’ Stock Analysis page.